Services
Interventional radiology
Our role Interventional radiology is a set of techniques that are minimally invasive and use medical imaging to visualise, access and act on an organ for the purposes of diagnosis and/or treatment. Image Image Image We use ultrasound, angiography, scanners and sometimes MRI to carry out biopsies or ablations, place a stent or inject a treatment. In principle, this is possible for all the systems and most of the organs of the human body. Dr Fadi Tannouri Head of the Interhospital Department of Interventional Radiology at the H.U.B Our specialities The H.U.B’s Interhospital Department of Interventional Radiology is divided into 5 sections:   Vascular disease and embolization covers arterial or venous angiography and angioplasty (placing of a stent and prosthesis, in cooperation with  vascular surgery) and embolization. The latter consists of blocking a blood vessel for therapeutic purposes, to stop haemorrhaging for example.   The osteoarticular  section covers infiltrations, biopsies, the thermoablation of bone tumours and cementoplasty (injection of intraosseous “cement”) with or without percutaneous osteosynthesis, in cooperation with orthopaedic surgery. The nephrology, urology and gynaecology  sector covers the embolization of uterine fibroids, of benign  prostatic hypertrophy and of pelvic  varicoceles and varicose veins, as well as nephrostomy. This section also provides vascular access for dialysis and creates arteriovenous fistula by percutaneous means.  The oncological section permits the placing of implantable ports and PICC lines (venous access),  pain management through infiltration, neuroloysis or radiofrequency as well as the treatment of certain cancers (see Focus).   The thoracic pathologies section covers biopsies, haemostatic embolization, percutaneous ablation of lung tumours and thermoablation of benign thyroid nodules.    Interventional radiology also covers biopsies and drainage under ultrasound, radiological or tomodensitomety (scanner) control.     Our team Image Our specialists Focus Interventional radiology is used for a minimally invasive treatment of certain cancers and benign tumours. A number of techniques are proposed:   The destruction of liver, kidney and lung tumours by thermoablation (radiofrequencies, microwaves and cryotherapy);   Chemoembolization, radioembolization and portal embolization;    Thermoablation of benign thyroid nodules ; Embolization of prostatic arteries in the framework of benign hypertrophy of the prostate gland.    Forward-looking studies Percutaneous AVF creation outcome and complications Prostate artery embolization: comparing embolic material Varicocele embolization: comparing embolic material
Radiologie Interventionnelle Vasculaire Et Générale - Erasme
Article
A rapid diagnosis pathway for colorectal cancer at the H.U.B
Teams from the Gastroenterology and Digestive Oncology Departments of the Erasmus Hospital and Jules Bordet Institute are now working hand-in-hand within the Brussels University Hospital (H.U.B).  They propose a rapid diagnosis pathway reserved for patients showing warning signs, a positive result in a search for blood in the stools or who are at high risk.  On 22 and 23 March a giant colon will be installed in the lobbies of the Erasmus Hospital and Jules Bordet Institute. Professionals from our institutions will be there on the day to help you discover this organ and highlight the importance of screening for colorectal cancer.     Essential screening   Every year more than 8,000 Belgians, both men and women, are diagnosed with colorectal cancer. In 90% of cases they are aged over 50. One third of these persons will die from their cancer due to a late diagnosis. If detected in time, 90% of these persons are cured.  Faced with this problem, our professionals decided to put into place a rapid diagnosis pathway for patients presenting a warning sign or a high risk.  Colonoscopy screening is essential as it reduces the risk of developing colorectal cancer and reduces the mortality by 50%. This examination has therapeutic as well as diagnostic benefits as it not only allows a cancer to be detected at an early stage but also prevents its occurrence by removing colorectal polyps and early cancers.    Who is the screening targeting?   You can make an appointment with our professionals who will rapidly schedule a colonoscopy if you present warning signs such as an unexplained and lasting change in bowel movements, the presence of blood in the stools, abdominal pain or unexplained weight loss. If you have a personal or family history of polyps and/or colorectal cancer, inflammatory diseases of the digestive tube (Crohn's disease or proctocolitis) or a family history of multiple polyposis or hereditary colon cancer you will be prioritised.    With or without warning signs, from the age of 50 you can also undergo a simple test for the presence of blood in the stools, carried out in your own home following an invitation sent by the Region.    Do you show any of these symptoms? Then make an appointment with our specialists who will schedule your tests as quickly as possible on the basis of your symptoms.    Gastroenterology consultation: • Jules Bordet Institute 02 541 34 80 • Erasmus 02 555 35 04  Screening consultation at the Jules Bordet Institute (if no symptoms): 02 541 30 00   A giant colon to boost awareness   March is awareness month for colorectal cancers. On this occasion the Brussels University Hospital invites you to come and discover a giant colon. Accompanied by health professionals you can actually go inside the structure to discover this organ, in 3D, and better understand why and how to protect yourself against colorectal cancer, one of the most deadly cancers in Belgium.  The dates are 22 March at the Erasmus Hospital between 9 am and 4 pm and 23 March at the Jules Bordet Institute between 9 am and 4 pm.   
Health issues
Rare diseases
Rare diseases function Patients with a rare disease must receive proper and specific care: a rapid diagnosis followed by treatment in care units with staff trained in these rare diseases. The mission of the Rare Diseases Function (8 in Belgium) is to coordinate, with teams with the required expertise, the care pathways and scientific research and training projects of all the professionals involved  in providing an adapted and constantly evolving care.  
Rare diseases
Article
Rare diseases: 8 questions to ask
Did you know that 8 questions asked to your patients can already guide you in the case of a rare disease? If you can answer most of these 8 questions with 'yes' and your intuition confirms it, it would be wise to consider a rare disease. Does the patient present with acute or chronic symptoms that are inexplicable, inconsistent or non-specific, or symptoms at an unusually young age? Is there a family history? Have there been a number of periods of illness with different or identical symptoms? Is there a history of consultations with different medical specialities without satisfactory results? Are there any pathological or borderline results that are inconclusive at first sight? Has there ever been any suspicion of psychosomatic aetiology? Have there been phases of the illness going back several years? Are certain exposure scenarios known (in relation to food, leisure activities, housing, animals, travel or work)? Do not hesitate to refer your patient to a health specialist or geneticist, preferably linked to one of our designated centres of expertise for rare diseases, who are better placed to make a diagnosis.  For more information, visit https://ulbgenetics.be/fonctions-maladies-rares/ * These 8 questions were written by rare disease experts involved in the EMRaDi project.
Health issues
Raynaud’s disease
What is Raynaud’s disease? Raynaud’s disease is a disorder that affects the blood circulation, principally in the fingers and toes but sometimes in the ears, nipples, knees or nose.  It is characterised by a vasospasm – sudden constrictions of the blood vessels that considerably reduce the blood flow to the extremities – most often triggered by an exposure to cold but also by emotional stress. It can exist as an isolated  condition (primary Raynaud’s disease), in which case it is observed more frequently in women and people living in colder climates. The exact cause of primary Raynaud’s disease is not known.      Raynaud’s disease also occurs in men and women with autoimmune diseases, diseases of the conjunctive tissue and also other diseases, most notably:  Systemic scleroderma  Disseminated lupus erythematosis Sjögren’s disease  Rheumatoid polyarthritis  Polymyositis  Pulmonary hypertension Buerger’s disease (thromboangiitis obliterans) In these cases one speaks of secondary Raynaud’s disease. What are the risk factors?  Although we don’t know why certain persons develop Raynaud’s disease, certain risk factors are known:  Pre-existing connective tissue Autoimmune disease Smoking Repetitive pressure exercised on the hands, by using vibrating tools for example (electric tools)  Injuries or traumas Exposure to chemical products Side effects of certain medicines (beta blockers)  Etc. Symptoms and diagnosis There are some very frequent symptoms encountered in Raynaud’s disease patients but each patient can experience different symptoms. The fingers and toes turn white, then blue – generally after having been exposed to cold air or cold objects, or after having suffered stress – and then turn red when warmed up again. In serious cases, sores develop at the ends of the fingers or toes. In rare cases the fingers or toes can become infected or gangrenous, requiring amputation in the absence of treatment.  How to diagnose Raynaud’s disease ? Patients in our medical clinic are initially assessed by a rheumatologist and, depending on the severity, they can also be examined by a vascular specialist.  A large part of the diagnosis will focus on assessing the symptoms. In addition to a complete medical history and a medical examination, our team will generally order at least one type of blood test. A patient may also undergo a cold provocation test to highlight the colour changes in the hands or feet. With secondary Raynaud’s disease it is also important to identify - and treat- the underlying autoimmune disease that may be at the origin of the Raynaud’s disease (for example systemic sclerodermia: see the Erasmus Hospital’s systemic sclerodermia reference centre).  An examination by capillaroscopy is carried out. This non-invasive and painless examination makes it possible to visualise the capillaries in the nail bed. In the case of secondary Raynaud’s disease, as in the case of systemic sclerodermia, a reduction in the number of capillaries is observed as well as  the presence of dilated capillaries.       Treatment After an in-depth evaluation the team of doctors will draw up a treatment plan based on the type and extent of the disease, the general health status of the patient and the patient’s preferences.   Although there is no cure for Raynaud’s disease, it can normally be managed with appropriate treatment, such as:  Lifestyle changes: Limit exposure to the cold by dressing warmly: gloves, socks, scarf, hat and several layers  Stop smoking to improve circulation and your health in general Avoid the use of vibrating tools. Medical treatment Alpha blockers suppress the response of the sympathetic nervous system that leads to vasoconstriction (narrowing of the blood vessels)  Other medicines improve the blood flow to the fingers and toes by dilating the blood vessels. These include  calcium channel inhibitors and phosphodiesterase  inhibitors. Avoid using beta blockers, generally used for treating high blood pressure and that slow the heart rate and reduce the blood flow to extremities For patients who do not show a sufficient response to the aforementioned medicines there can be experimental medicine options - medicines that can be used in clinical trials. 
Raynaud’s disease
Rich page
Red Blood Cell Day 2025
On Thursday 20 February 2025, the ‘Red Blood Cell’ group of the Belgian Haematology Society and the H.U.B. are organising the next Red Blood Cell Day. Discover the programme and the speakers.  Program & speakers This event will take place at the Jules Bordet Institute, Rue Meylemeersch 90, 1070 Anderlecht, in the Tagnon Auditorium, 1st FloorSession for healthcare professionals09h00Eosinophils and SCD : Bad couple ?S. Karimi (HUB - Brussels)09h30Sickle Cell NephropathyV. Labarque (KUL - Leuven)10h00Vaccination in SCD - What is a realistic approach ?M. Hoyoux (CHU Liège - Citadelle)10h30Coffee Break 10h50Immunological and Practical Aspects of Transfusion in HemoglobinopathiesV. Deneys (CUSL - UCL - Brussels)11h20Transfusional Optimization in Transfusion-Dependent ThalassemiaG. De Luna  (Henri Mondor -APHP - Paris)11h50HSCT in Hbpathies : New regimens versus new therapiesF. Bernaudin (CHIC - Paris)12h20Cerebrovascular workup in SCDB. Biemond (UMC - Amsterdam)13h00Lunch 14h00Diagnostic pitfalls and New Therapies in RBC EnzymopathiesF. Galacteros (Henri Mondor -APHP - Paris)14h30Clinical reesearch in remote region - Experience in DRCB. Mbiya (Centre Mashi - Mbujimayi)15h00Systemic racism vs Care : A sickle cell perspectiveM. Shema (UMF lasi)15h30Pain at Home - Evolution of pain after hospital dischargeL. Vinguetama-Périanagom (ULB - Brussels)16h00Alternatives to opioïd analgesiaC. Greco (Necker-Enfants Malades - APHP - Paris)16h30Coffee Break Session for patients16h45Non-opioid analgesicsS. Hatton (Necker-Enfants Malades - APHP - Paris)17h15NutritionV. Hannecart (HUB - Brussels) & K. Egberts DrepaCoach17h45Access to healthcare and the stay or return of sick peopleS. Jassogne & K. Vanhees - Medimmigrant asbl18h45End of the event  Inscription - Professionnels de santé Inscription - Patients En collaboration avec